FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953500290> ?p ?o ?g. }

• W2953500290 endingPage "29" @default.
• W2953500290 startingPage "21" @default.
• W2953500290 abstract "Aim. To study the clinical course of atrial fibrillation in patients with arterial hypertension and extracardiac comorbid pathology depending on the administered therapy. Methods. 207 men aged 45–65 years with atrial fibrillation (paroxysmal and persistent) and arterial hypertension in combination with diabetes mellitus (n = 40), abdominal obesity (n = 64) and chronic obstructive pulmonary disease (n = 47) were recruited to a observational cohort study. 56 patients with atrial fibrillation and arterial hypertension but without any extracardiac diseases were included in the comparison group. Clinical and anthropometric parameters were assessed in all patients. Adherence to therapy was estimated with the Morisky-Green test. All patients underwent ECG; electrocardiographic holter monitoring, 24-hour blood pressure monitoring with the Daily Monitoring Systems SCHILLER (Schiller, Switzerland), 2D and M-mode echocardiography using a Vivid 7 device (General Electric, USA). The statistical analysis was performed in the Rstudio software (version 0.99.879, RStudio, Inc., MA, USA). Results. 66% of patients with atrial fibrillation and arterial hypertension had concomitant extracardiac comorbid pathology, of them 20% of had diabetes mellitus, 22% with chronic obstructive pulmonary disease, and 24% with abdominal obesity. The clinical groups were comparable in electro impulse and drug therapy. Patients who received medical treatment were frequently admitted to hospitals for atrial fibrillation recurrence (p<0.001), compared with those who underwent electro impulse therapy. Adherence to antiarrhythmic therapy was low in the entire cohort of patients. There were no significant differences found between the clinical groups. Conclusion. Early diagnosis of the factors contributing to the progression of AF, the prescription of additional therapy for the secondary prevention of arrhythmia and the choice of its optimal treatment strategy may slow the progression of arrhythmia and the development of CHF, which will improve not only the clinical status of patients, but also their prognosis." @default.
• W2953500290 created "2019-07-12" @default.
• W2953500290 creator A5010445753 @default.
• W2953500290 creator A5035617344 @default.
• W2953500290 creator A5068109341 @default.
• W2953500290 date "2019-06-23" @default.
• W2953500290 modified "2023-09-26" @default.
• W2953500290 title "ATRIAL FIBRILLATION IN COMORBID PATIENTS DEPENDING ON THE TREATMENT REGIMEN" @default.
• W2953500290 cites W1993468833 @default.
• W2953500290 cites W2039860387 @default.
• W2953500290 cites W2054893624 @default.
• W2953500290 cites W2133369189 @default.
• W2953500290 cites W2615954481 @default.
• W2953500290 cites W2750380826 @default.
• W2953500290 cites W2804987717 @default.
• W2953500290 cites W2890716402 @default.
• W2953500290 cites W2903116006 @default.
• W2953500290 cites W4250697293 @default.
• W2953500290 cites W75245760 @default.
• W2953500290 doi "https://doi.org/10.17802/2306-1278-2019-8-2-21-29" @default.
• W2953500290 hasPublicationYear "2019" @default.
• W2953500290 type Work @default.
• W2953500290 sameAs 2953500290 @default.
• W2953500290 citedByCount "4" @default.
• W2953500290 countsByYear W29535002902020 @default.
• W2953500290 countsByYear W29535002902022 @default.
• W2953500290 countsByYear W29535002902023 @default.
• W2953500290 crossrefType "journal-article" @default.
• W2953500290 hasAuthorship W2953500290A5010445753 @default.
• W2953500290 hasAuthorship W2953500290A5035617344 @default.
• W2953500290 hasAuthorship W2953500290A5068109341 @default.
• W2953500290 hasBestOaLocation W29535002901 @default.
• W2953500290 hasConcept C126322002 @default.
• W2953500290 hasConcept C134018914 @default.
• W2953500290 hasConcept C164705383 @default.
• W2953500290 hasConcept C2779161974 @default.
• W2953500290 hasConcept C2779384505 @default.
• W2953500290 hasConcept C555293320 @default.
• W2953500290 hasConcept C71924100 @default.
• W2953500290 hasConcept C72563966 @default.
• W2953500290 hasConcept C80093799 @default.
• W2953500290 hasConceptScore W2953500290C126322002 @default.
• W2953500290 hasConceptScore W2953500290C134018914 @default.
• W2953500290 hasConceptScore W2953500290C164705383 @default.
• W2953500290 hasConceptScore W2953500290C2779161974 @default.
• W2953500290 hasConceptScore W2953500290C2779384505 @default.
• W2953500290 hasConceptScore W2953500290C555293320 @default.
• W2953500290 hasConceptScore W2953500290C71924100 @default.
• W2953500290 hasConceptScore W2953500290C72563966 @default.
• W2953500290 hasConceptScore W2953500290C80093799 @default.
• W2953500290 hasIssue "2" @default.
• W2953500290 hasLocation W29535002901 @default.
• W2953500290 hasOpenAccess W2953500290 @default.
• W2953500290 hasPrimaryLocation W29535002901 @default.
• W2953500290 hasRelatedWork W1967841144 @default.
• W2953500290 hasRelatedWork W2017505888 @default.
• W2953500290 hasRelatedWork W2033859460 @default.
• W2953500290 hasRelatedWork W2039867927 @default.
• W2953500290 hasRelatedWork W2087201732 @default.
• W2953500290 hasRelatedWork W2319489406 @default.
• W2953500290 hasRelatedWork W2415759662 @default.
• W2953500290 hasRelatedWork W2918185451 @default.
• W2953500290 hasRelatedWork W3212442384 @default.
• W2953500290 hasRelatedWork W4246478000 @default.
• W2953500290 hasVolume "8" @default.
• W2953500290 isParatext "false" @default.
• W2953500290 isRetracted "false" @default.
• W2953500290 magId "2953500290" @default.
• W2953500290 workType "article" @default.